Even though most viruses cause infection directly through mucosal cells, the vast majority of vaccines are administered intramuscularly in a cellular mismatch that doesn't always produce optimum immunity.
Adults (aged 18 or older) hospitalized with COVID-19 are at higher risk of complications and death than those with influenza, despite being younger and having fewer chronic illnesses, according to a retrospective cohort study ...
Apr 22, 2022
0
140
Researchers from the Medway School of Pharmacy (a partnership between the universities of Kent and Greenwich) have helped isolate the Lloviu virus (LLOV)—a close relative of Ebola virus—for the first time, highlighting ...
May 6, 2022
0
211
Research recently published in Clinical Infectious Diseases from the University of Minnesota Medical School has found that Fecal Microbiota Transplantation, or FMT, is an optimal cost-effective treatment for first recurrent ...
Jun 2, 2022
0
3
For 60 years, doctors and scientists searched for a vaccine against a common virus that, while sometimes deadly, is little known to the public. The hunt is over.
May 6, 2023
0
26
People with the "hybrid immunity" of having been both fully vaccinated and previously infected with COVID-19 have the strongest protection against the virus, two new studies said on Friday.
Apr 1, 2022
0
207
Infectious diseases expert George Thompson has been studying and treating fungal diseases for over two decades. He monitors their spread, symptoms and relative risks. Lately, he has been more concerned about a rising threat: ...
Nov 21, 2022
0
237
A new study presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) and published in The Lancet Rheumatology, shows that the antibody—but not the T-cell—response to the first ...
Jul 9, 2021
0
2
New research to be presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Lisbon, Portugal, (23-26 April), has shown that a longer interval between primary COVID-19 vaccine doses ...
Apr 22, 2022
0
45
A rare autoimmune condition with a tongue-twister of a name may impact people of Puerto Rican heritage through a newly discovered genetic pathway, a discovery that may ultimately guide genetic counseling and treatment, scientists ...
